Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | marketing@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36?Washington?Street, Wellesley?Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
Diphenidol;Difenidol;SKF 478;Difenidolo;SKF-478;SKF478 | C21H27NO | 972-02-1 | Details |
7H-Benzimidazo(2,1-a)benz(de)isoquinolin-7-one | C18H10N2O | 23749-58-8 | Details |
Irbesartan HCl;BMS 186295;BMS186295;Irbesartan hydrochloride;BMS-186295 | C25H29ClN6O | 329055-23-4 | Details |
Abediterol napadisylate;LAS100977 napadisylate | C35H38F2N2O10S2 | 1044516-17-7 | Details |
Pralatrexate, (S)- | C23H23N7O5 | 1320211-69-5 | Details |
Benzil;NSC 220315;NSC-220315;NSC220315 | C14H10O2 | 134-81-6 | Details |
RuBi-4AP | C30H28ClN8Ru+ | 851956-02-0 | Details |
SB 258719 hydrochloride | C18H31ClN2O2S | 1217674-10-6 | Details |
Histrelin;Supprelin LA;Histrelin Acetate | C66H86N18O12 | 76712-82-8 | Details |
Pirimicarb | C11H18N4O2 | 23103-98-2 | Details |
ACPT-II | C8H11NO6 | 195209-04-2 | Details |
DMAB-anabaseine dihydrochloride | C19H22ClN3 | 154149-38-9 | Details |
JNJ28871063 hydrochloride;JNJ 28871063 hydrochloride | C24H28Cl2N6O3 | 944342-90-9 | Details |
TMPH hydrochloride | C16H32ClNO2 | 849461-91-2 | Details |
Diisooctyl sebacate;diisooctyl ester;Decanedioic acid | C26H50O4 | 27214-90-0 | Details |
LY 53857;LY-53857;LY53857 | C27H36N2O7 | 60634-51-7 | Details |
sPLA2 inhibitor 1 | C31H37NO4 | 393569-31-8 | Details |
L-838417 | C19H19F2N7O | 286456-42-6 | Details |
C.I. Vat Brown 3 | C42H23N3O6 | 131-92-0 | Details |
SL 0101-1 | C25H24O12 | 77307-50-7 | Details |
MMPP | C17H18O3 | 1895957-18-2 | Details |
FAUC 213 | C18H19ClN4 | 337972-47-1 | Details |
Gatifloxacin mesylate | C19H22FN3O4.CH4O3S | 316819-28-0 | Details |
Losartan potassium impurity E;L-158507;L158507;L 158507 | C14H12N4 | 120568-11-8 | Details |
HM-50316;HM 50316;HM50316 | C29H23ClN2O3S | 1310361-52-4 | Details |
CHMFL-FLT3-122;CHMFLFLT3122;CHMFL FLT3 122 | C26H29N7O2 | 1839150-56-9 | Details |
rac-CCT-250863 | C24H25F3N4O2S | 1364269-06-6 | Details |
A331440;A331440 free base;A 331440;A-331440 | C22H27N3O | 392338-13-5 | Details |
Butaprost;TR-4979;(R)-Butaprost;Butaprostum | C24H40O5 | 69648-38-0 | Details |
JNJ-10311795;JNJ10311795;JNJ 10311795 | C40H35N2O6P | 518062-14-1 | Details |
L-796568 free base;L 796568 free base;L796568 free base | C31H27F3N4O3S2 | 211031-01-5 | Details |
OBI-3424 | C21H25N4O6P | 2097713-68-1 | Details |
Myrtenal;NSC54384;NSC-54384;Benihinal;NSC 54384 | C10H14O | 564-94-3 | Details |
UBP-282;UBP 282 | C15H15N3O6 | 544697-47-4 | Details |
WST-1;WST 1;WST1 | C19H11IN5NaO8S2 | 150849-52-8 | Details |
1,2-Dilauroyl-sn-glycerol;(S)-1,2-Dilaurin;1,2-DLG | C27H52O5 | 60562-15-4 | Details |
NH2-PEG3-C2-Boc;Amino-PEG3-t-butyl ester | C13H27NO5 | 252881-74-6 | Details |
Quinpirole dihydrochloride;(±)Quinpirole dihydrochloride;LY 141865;(±)-Quinpirole dihydrochloride;Quinpirole 2HCl;LY-141865 | C13H22ClN3 | 73625-62-4 | Details |
Hydrastinine hydrochloride | C11H13NO3.ClH | 4884-68-8 | Details |
Cellufluor;Tinopal 5BMS;Kayaphor FB;Phorwite AR;Paper White BP | C40H45N12NaO10S2 | 4193-55-9 | Details |
RL648_81 | C17H17F4N3O2 | 1919050-87-5 | Details |
WJ460 | C27H28N2O3S | 1415251-36-3 | Details |
BCTP | C17H16ClN3OS | 464152-46-3 | Details |
Irganox 1010 | C73H108O12 | 6683-19-8 | Details |
NF-1819 | C24H22FN5O4 | 1881244-28-5 | Details |
TC-G 1000 | C17H18N2O4S | 245744-18-7 | Details |
PF-06372222;PF 0637222;PF0637222;PF-0637222 | C26H28F3N5O3 | 1407592-99-7 | Details |
C188;STAT3-IN-C188;C 188;Cpd-188;C-188;Cpd188 | C19H15NO7S2 | 823828-18-8 | Details |
6bK;6 bK;IDE-IN-6bK;IDE-inhibitor-6bK;6-bK;IDE inhibitor 6bK | C43H56F3N7O9 | 1774353-12-6 | Details |
MRT-68601 HCl;MRT 68601 HCl;MRT68601 HCl | C25H34N6O2 | 1190379-37-3 | Details |
BRD0476;BRD-0476;BRD 0476;ML 187;ML-187;ML187 | C35H38N4O8S | 1314958-91-2 | Details |
SA-16;SA 16;SA16 | C33H24F2N6O4 | 1919884-11-9 | Details |
Neladenoson dalanate HCl;Neladenoson dalanate hydrochloride | C35H35Cl2N7O4S2 | 1239235-25-6 | Details |
Tazofelone | C18H27NO2S | 107902-67-0 | Details |
YKL-5-124 | C28H33N7O3 | 1957203-01-8 | Details |
IMTPPE;SID3712502;SID-3712502;SID 3712502 | C20H27N3O2S | 851688-13-6 | Details |
IDT | C8H5NS2 | 18138-19-7 | Details |
BIBO3304;BIBO-3304;BIBO 3304 | C29H35N7O3 | 191868-13-0 | Details |
LBT 999;LBT999;LBT-999 | C20H26FNO2 | 877467-20-4 | Details |
Dasolampanel etibutil | C23H32ClN5O3 | 503291-52-9 | Details |
Roseoflavin | C18H23N5O6 | 51093-55-1 | Details |
Rabacfosadine succinate;VDC-1101 succinate;GS-9219 succinate;GS-9219-01;VDC 1101 succinate VDC1101 succinate | C25H41N8O10P | 1431856-99-3 | Details |
Mosapramine;Y516;Y-516;Clospipramine;Cremin;Y 516 | C28H35ClN4O | 89419-40-9 | Details |
Cipralisant maleate;GT2331;Cipralisant maleate. trade name Perceptin;GT-2331;GT 2331 | C18H24N2O4 | 223420-20-0 | Details |
Reltecimod sodium;AB 103 sodium;AB-103 sodium;AB103 sodium | C46H73N10NaO15S | 1943755-99-4 | Details |
ChX710 | C18H21N5O | 2438721-44-7 | Details |
K67 | C29H30N2O7S2 | 2046250-48-8 | Details |
Alflutinib | C28H31F3N8O2 | 1869057-83-9 | Details |
Telratolimod | C36H59N5O2 | 1359993-59-1 | Details |
Asalhydromorphone | C35H31NO9 | 1431529-94-0 | Details |
Cyheptamide;AY 8682;AY-8682 | C16H15NO | 7199-29-3 | Details |
Cystamine dihydrochloride | C4H14Cl2N2S2 | 56-17-7 | Details |
Acetylcholine perchlorate;AI3-51678;AI351678;AI3 51678 | C7H16ClNO6 | 927-86-6 | Details |
Incadronate Disodium;YM 175;YM175;Cimadronate;YM-175 | C8H20NNaO6P2 | 138330-18-4 | Details |
Etofenprox | C25H28O3 | 80844-07-1 | Details |
Flucythrinate | C26H23F2NO4 | 70124-77-5 | Details |
Phenyl butyrate;AI3-11761;AI3 11761;AI311761 | C10H12O2 | 4346-18-3 | Details |
Tetrahexyldecyl ascorbate | C70H128O10 | 183476-82-6 | Details |
EcDsbB-IN-9 | C11H8Cl2N2O | 41933-33-9 | Details |
Caprolactam | C6H11NO | 105-60-2 | Details |
CCMQ | C12H9NO4 | 132623-44-0 | Details |
Flamprop-methyl;Lancer;WL29761;Suffix plus;WL 29761;Super-Suffix;WL-29761 | C17H15ClFNO3 | 52756-25-9 | Details |
Zatebradine hydrochloride | C26H37ClN2O5 | 91940-87-3 | Details |
cis-3-Hexen-1-ol | C6H12O | 928-96-1 | Details |
Buflomedil;Buflomedilum | C17H25NO4 | 55837-25-7 | Details |
Chlorotriphenylmethane;NSC435;NSC-435;TriphenylMethyl chloride;NSC 435 | C19H15Cl | 76-83-5 | Details |
3,5-Dinitro-p-toluic acid | C8H6N2O6 | 16533-71-4 | Details |
LY 231617 | C17H30ClNO | 141545-89-3 | Details |
p,p'-DDD;p,p’-DDD;Rothane;TDE;DDD;Dilene | C14H10Cl4 | 72-54-8 | Details |
MT-7;MT7;MT 7 | C22H17N3O2 | 946507-08-0 | Details |
Erucin | C6H11NS2 | 4430-36-8 | Details |
BNP (1-32), human | C143H244N50O42S4 | 114471-18-0 | Details |
Acridine red;CI 45000;C.I. 45000;3B Acridine red hydrochloride | C15H15ClN2O | 2465-29-4 | Details |
GR 46611 | C23H27N3O2 | 185259-85-2 | Details |
L-Alaninol | C3H9NO | 2749-11-3 | Details |
Fentiazac;Donorest;Flogene;BR-700 | C17H12ClNO2S | 18046-21-4 | Details |
5'-O-Tritylthymidine;M 13;M13;M-13;Monotritylthymidine | C29H28N2O5 | 7791-71-1 | Details |
SP-Chymostatin B;alpha-Mapi | C30H41N7O6 | 70857-49-7 | Details |
Methylsilanol acetylmethionate | C8H17NO5SSi | 105883-43-0 | Details |
MSN-50;MSN 50;MSN50 | C36H38BrN3O6 | 1592908-75-2 | Details |
Product Total: Product Page: | ||||
220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 |